As cyberthreats to medical research on COVID-19 – and other intellectual property – grow, organizations must take critical steps to prevent the theft of their “innovation capital,” says Russell Koste, Chief Security Officer at Alexion Pharmaceuticals, and one of the HSCC CWG Leaders on the Health Industry Cybersecurity Protection of Innovation Capital (HIC-PIC)
